268 related articles for article (PubMed ID: 24346990)
1. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury.
Gandhi S; Fleet JL; Bailey DG; McArthur E; Wald R; Rehman F; Garg AX
JAMA; 2013 Dec; 310(23):2544-53. PubMed ID: 24346990
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel blocker-clarithromycin drug interaction did not increase the risk of nonvertebral fracture: a population-based study.
Fraser LA; Shariff SZ; McArthur E; Naylor KL; Garg AX
Ann Pharmacother; 2015 Feb; 49(2):185-8. PubMed ID: 25429094
[TBL] [Abstract][Full Text] [Related]
3. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.
Patel AM; Shariff S; Bailey DG; Juurlink DN; Gandhi S; Mamdani M; Gomes T; Fleet J; Hwang YJ; Garg AX
Ann Intern Med; 2013 Jun; 158(12):869-76. PubMed ID: 23778904
[TBL] [Abstract][Full Text] [Related]
4. Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants.
Hill K; Sucha E; Rhodes E; Carrier M; Garg AX; Harel Z; Hundemer GL; Clark EG; Knoll G; McArthur E; Sood MM
JAMA Intern Med; 2020 Aug; 180(8):1052-1060. PubMed ID: 32511684
[TBL] [Abstract][Full Text] [Related]
5. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers.
Wright AJ; Gomes T; Mamdani MM; Horn JR; Juurlink DN
CMAJ; 2011 Feb; 183(3):303-7. PubMed ID: 21242274
[TBL] [Abstract][Full Text] [Related]
6. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.
Li DQ; Kim R; McArthur E; Fleet JL; Bailey DG; Juurlink D; Shariff SZ; Gomes T; Mamdani M; Gandhi S; Dixon S; Garg AX
CMAJ; 2015 Feb; 187(3):174-180. PubMed ID: 25534598
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole.
Mishima E; Maruyama K; Nakazawa T; Abe T; Ito S
Intern Med; 2017; 56(13):1687-1690. PubMed ID: 28674358
[TBL] [Abstract][Full Text] [Related]
8. Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin.
Takeuchi S; Kotani Y; Tsujimoto T
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28069789
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers + macrolides: elderly patients hospitalised for low blood pressure.
Prescrire Int; 2012 Jul; 21(129):182. PubMed ID: 22852287
[TBL] [Abstract][Full Text] [Related]
10. Adverse events with quetiapine and clarithromycin coprescription: A population-based retrospective cohort study.
Yau K; McArthur E; Jeyakumar N; Tsobo Muanda F; Kim RB; Clemens KK; Wald R; Garg AX
Health Sci Rep; 2023 Jun; 6(6):e1375. PubMed ID: 37359413
[TBL] [Abstract][Full Text] [Related]
11. Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study.
Wang YC; Hsieh TC; Chou CL; Wu JL; Fang TC
Medicine (Baltimore); 2016 Jan; 95(2):e2487. PubMed ID: 26765458
[TBL] [Abstract][Full Text] [Related]
12. Drug-drug interactions and acute kidney injury: caveat prescriptor.
Mendu ML; Waikar SS
Am J Kidney Dis; 2014 Oct; 64(4):492-4. PubMed ID: 24820318
[No Abstract] [Full Text] [Related]
13. Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.
Hutson JR; Fischer HD; Wang X; Gruneir A; Daneman N; Gill SS; Rochon PA; Anderson GM
Drugs Aging; 2012 Mar; 29(3):205-211. PubMed ID: 22372724
[TBL] [Abstract][Full Text] [Related]
14. Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions.
Fleet JL; Shariff SZ; Bailey DG; Gandhi S; Juurlink DN; Nash DM; Mamdani M; Gomes T; Patel AM; Garg AX
BMJ Open; 2013; 3(7):. PubMed ID: 23847265
[TBL] [Abstract][Full Text] [Related]
15. Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.
Trac MH; McArthur E; Jandoc R; Dixon SN; Nash DM; Hackam DG; Garg AX
CMAJ; 2016 Apr; 188(7):E120-E129. PubMed ID: 26903359
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
[TBL] [Abstract][Full Text] [Related]
17. Risk of hypotension with concomitant use of calcium-channel blockers and macrolide antibiotics.
Henneman A; Thornby KA
Am J Health Syst Pharm; 2012 Jun; 69(12):1038-43. PubMed ID: 22644980
[TBL] [Abstract][Full Text] [Related]
18. Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.
Quinn KL; Macdonald EM; Gomes T; Mamdani MM; Huang A; Juurlink DN;
Drug Saf; 2017 Sep; 40(9):835-840. PubMed ID: 28421551
[TBL] [Abstract][Full Text] [Related]
19. Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not?
Szałek E; Karbownik A; Połom W; Matuszewski M; Sobańska K; Urjasz H; Grabowski T; Wolc A; Grześkowiak E
Pharmacol Rep; 2012; 64(6):1554-9. PubMed ID: 23406766
[TBL] [Abstract][Full Text] [Related]
20. Outcomes Following Macrolide Use in Kidney Transplant Recipients.
Jeong R; Quinn RR; Lentine KL; Lloyd A; Ravani P; Hemmelgarn B; Braam B; Garg AX; Wen K; Wong-Chan A; Gourishankar S; Lam NN
Can J Kidney Health Dis; 2019; 6():2054358119830706. PubMed ID: 30815270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
